Series A · BiotechVedana Therapeutics: Series ADevelops next-generation therapies for migraine preventionPublished Oct 4, 2026By RoundOS Funding deskFunding historyJun 17, 2026Series A · This round$46MSourcesbusinesswire.com↗
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.UndisclosedSeed · Oct 23, 2026
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200MPrivate financing · Oct 23, 2026
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237MSeries E · Oct 23, 2026
Warp SciencesWarp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.$215MSeries A · Oct 22, 2026